MDM2 and hepatocellular carcinoma: The HaKai heterodimer has been shown to promote the degradation of E-calmodulin, resulting in the nuclear translocation of β-catenin proteins and ultimately driving epithelial-mesenchymal transition (EMT) in HCC (38).However, the homologous structural domain type MDM2 may be a repressor of HCC.